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Coordination of the primary defense mechanisms against pathogens relies on the appropriate expression of
pathogen recognition receptors (PRRs) triggering the early release of effector molecules of the innate immune
system. To analyze the impact of this system on the counteraction of infections of the mammary gland
(mastitis), we characterized the bovine gene encoding the key PRR Toll-like receptor 9 (TLR9) and mapped its
precise position on chromosome BTA22. The sequence information was used to establish real-time PCR
quantification assays to measure the mRNA abundances of TLR9, TLR2, and TLR4 together with those of
-defensin 5 (BNBD5), an early bactericidal effector molecule of the innate system, in healthy and infected
mammary glands. Mastitis strongly increased (4- to 13-fold) the mRNA abundances of all of these genes except
TLR9. Slight subclinical infections already caused a substantial increase in the copy numbers, though they did
so the least for TLR9. Induction was not systemic, since mRNA abundance was low in uninfected control
quarters of the udder but high in the severely infected quarters of the same animal. The number of TLR2 copies
correlated well with those of TLR4, indicating coordinated regulation of these two PRRs during infection of the
udder. Their coordinated regulation explains our unexpected observation that pure Staphylococcus aureus
infections caused a strong increase also in TLR4 mRNA abundance. In situ hybridizations revealed that
BNBD5 is expressed predominantly in the mammary epithelial cells (MEC) of the infected gland. Our data
therefore suggest a significant contribution of the innate immune system to counteract mastitis and attribute
a prominent effector function to the MEC.
Infections of the mammary gland (mastitis) are the most
costly single trait diseases in dairy cattle housing (48). They are
caused by a broad spectrum of bacterial and fungal pathogens.
Invading pathogens activate the immune defense in the udder,
which is manifest as an increase of somatic cells in the milk.
Mainly polymorph nuclear neutrophil granulocytes are re-
cruited to the gland (38, 40), and their numbers increase 10- to
50-fold during the first few hours after infection (22, 23). The
etiology of the pathogens influences the severity of the inflam-
mation. Contagious pathogens, like Staphylococcus aureus or
Streptococcus agalactiae, tend to result in chronic, subclinical
mastitis while the environmental coliform bacteria very often
cause acute, clinical infections of the gland (17). The reasons
for these pathogen-related differences in the ability of the
host’s immune defense system to cope with infections of the
mammary gland are unknown. They might reside in factors
contributing to the innate branch of the immune system, since
the Toll-like receptor (TLR) pathogen receptors and the -de-
fensin-type bactericidal effector molecules of the innate im-
mune system are both known to display some pathogen spec-
ificity. However, there are no systematic reports available on
the mammary gland-specific or mastitis-related expression of
any key factor of the innate immune system.
TLRs signal the presence of pathogens to the mammalian
host (1, 25). They are prominently expressed in antigen-
presenting cells, notably macrophages and dendritic cells (27),
and are activated by pathogen-associated molecular patterns
(PAMPs). They stimulate the innate immune system (5) as well
as the adaptive system (32). Ten different TLRs (TLR1 to
TLR10) have been identified in mammals (16, 41). Different
TLRs are stimulated by different PAMPs (19), in part related
to the species of the pathogen. TLR4 but not TLR2, for ex-
ample, together with CD14, recognizes the presence of li-
poprotein A, a component of the lipopolysaccharide (LPS)
from gram-negative bacteria (24). TLR2 is activated inside the
phagosome by peptidoglycans from gram-positive bacteria (7,
52).
TLR 9 is of pivotal importance to the mounting of the full
immune defense. It is activated by unmethylated CpG dinucle-
otides of bacterial DNA (4, 20). Unmethylated CpG dinucle-
otides are known to act as strong adjuvants for TH1 and cyto-
toxic-T-cell responses as well as to promote the maturation of
dendritic cells (49). Moreover, the demonstrated lack of TH1
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helper function in TLR9-null mice (20) indicates a severe
lesion in these animals to stimulate the adaptive immune re-
sponse. TLR9s from humans and mice display species-specific
CpG motif recognition (4). Prior to this report, the DNA
sequence and gene structure of the bovine TLR9-encoding
gene were unknown.
-Defensins constitute a structural group of the broad vari-
ety of bactericidal peptides (44, 57). They are expressed in
epithelial cells (14, 35, 43) and also expressed abundantly in
polymorphonuclear cells (PMNs). Expression of the human
-defensin-2-encoding gene is triggered via TLR-mediated
NF-B activation (6). Likewise, LPS stimulates expression of
the bovine tracheal antibacterial peptide-encoding gene via
activation of NF-B (13). The bactericidal activities of some
-defensins differ against various pathogens, as is known for
humans (29, 42) and for some members of the 13 -defensin-
encoding genes in cattle (45).
-Defensin 1 has recently been detected in the mammary
glands of women (26), conceivably protecting the gland against
infections. However, while a -defensin-like bactericidal activ-
ity was isolated from bovine teats more than 30 years ago (21),
no recent account has been given on the significance of -de-
fensin activity to counteract mastitis inside the udder. Thus, we
set out to examine whether mastitis activates the innate im-
mune system in the udder, as indicated by enhanced expression
of TLRs and -defensins in the gland. We chose to determine
the expression of TLR2 and TLR4 as the likely receptors for
PAMPs from gram-positive and -negative bacteria, respec-
tively. TLR9 should complement the selection of TLRs, since
it acts as a strong adjuvant for the mounting of the immune
response. Hence, we characterized the bovine TLR9 cDNA
sequence and mapped the gene in cattle. We selected the gene
encoding -defensin 5 (BNBD5) as a candidate for effector
molecules of the innate system, since we had previously iso-
lated the mRNA of this gene from infected udders and se-
quenced the entire cDNA and encoding gene. A detailed char-
acterization of this gene will be given elsewhere (C. Pitra,
W. Yang, and H. M. Seyfert, unpublished data). Samples from
healthy and infected udders were collected, the pathogens
were typed, and three questions were asked. (i) Would mastitis
increase the abundance of factors contributing to the innate
immune defense system in the udder of the cow? (ii) Would
different species groups of mastitis bacteria exert a differential
influence upon TLR2 versus TLR4 expression during true
mastitis infections? (iii) Would gram-positive bacteria also in-
duce the expression of BNBD5, shown by in vitro tests to be
active against gram-negative bacteria only (45)?
MATERIALS AND METHODS
Collection of tissues and typing of pathogens. Udder tissue samples were
collected aseptically from slaughtered cows within 5 to 10 min after killing.
Glands were pathologically and anatomically categorized as inflamed (presump-
tively infected; n  19) and healthy (presumptively uninfected; n  19) glands.
Washed udder skin was heat sterilized and incised with a disinfected (70%
alcohol) knife. A piece of tissue (5 by 5 by 5 cm) was removed from a deeper area
of the udder quarter. A small section (0.5 by 0.5 by 0.5 cm) thereof was preserved
in RNA later (Qiagen, Hilden, Germany) for RNA analysis. Bacterial contam-
ination (grade and bacterial species) was determined from two fresh slices (du-
plicates) of the tissue sample after a smear test with standard bacteriological
techniques. The degree of bacterial contamination was evaluated after cultiva-
tion on blood agar (24 h, 37°C) and categorized as uninfected if no colonies
formed (0 CFU). Slight, moderate, and severe infections were assumed if sam-
ples gave rise to 1 to 10, 11 to 30, and 31 CFU, respectively. Substances
inhibitory to bacterial growth (e.g., residuals from antibiotics) were not detected
in any sample.
Isolation of the bovine TLR9 cDNA and genomic copy of the encoding gene. (i)
cDNA isolation. We followed the general procedures for RNA extraction and
reverse transcription (RT)-PCR set-up as previously described (30). One micro-
gram of total RNA extracted from an infected udder was primed in reverse with
an oligo(dT) nucleotide primer. Initially, two different segments of the bovine
TLR9 were amplified with two different sets of primer pairs. The primers had
been placed on sequence elements well conserved between mice and humans.
The primers TLR9 forward (5-GCCTTCCTACCCTGTGAGCT) and reverse
(5-GMGGTCAGATTGGCCAGGTC[M, C, or A]) amplified 644 bp from the
5-terminal half of the message. Primers TLR9E4f (5-TGTTTGTGCTGGCCC
ACACGGAC) and TLR9E4r (5-GCAGGATCACCAGCACTACGA) ampli-
fied a 114-bp segment from the 3 terminus of the cDNA. Subcloning and
sequencing revealed that the products contained the expected copies from the
bovine TLR9 message. Subsequently, the oligonucleotides TLR9f and TLR9E4r
were used to amplify the large segment of the bovine TLR9 cDNA.
(ii) RACE experiments. We used the GeneRacer kit (Invitrogen, Karlsruhe,
Germany) to establish the 5 end of the cDNA sequence and the Marathon
random amplification of cDNA ends (RACE) kit from Stratagene (La Jolla,
Calif.) for the 3 end.
(iii) Isolation of genomic copies from BAC libraries. Genomic copies of the
bovine TLR9-encoding gene were retrieved from the bovine bacterial artificial
chromosome (BAC) library BBI-B750 (58) of the RZPD Resource Center (Ber-
lin, Germany) based on PCR screenings. Primers 5-CACCATCTTCAACGAC
CTGA and 5-TCTCCAGGGACACCAGACTC amplified a 122-bp segment of
the bovine TLR9-encoding gene from these BAC stocks, and the isolates were
stored as our BAC clones 820 and 821. BAC 820 was used for further analyses.
Chromosome assignment of the bovine TLR9-encoding gene. (i) Chromosome
preparation and FISH. Metaphase spreads were prepared from fibroblast cul-
tures by standard cytogenetic techniques. Chromosomes were G banded and
Giemsa stained. For fluorescence in situ hybridization (FISH), G-banded meta-
phase spreads were digitized with MacKtype karyotype analysis software (Per-
ceptive Scientific Instruments, Inc., League City, Tex.). Chromosomes were
karyotyped according to the International System for Chromosome Nomencla-
ture of Domestic Bovids for bovine G-banded chromosomes (11). BAC clone 820
harboring the bovine TLR9-encoding gene was used as a hybridization probe. It
was labeled with biotin-16-dUTP with a nick translation system kit (Invitrogen).
The DNA mixture was prepared with 0.5 g of the probe, 5 g of bovine C0t-1
DNA (prepared according to the method of Young and Anderson [56]), and 20
g of salmon sperm DNA. Bound probe molecules were detected with fluores-
cein isothiocyanate-labeled anti-biotin antibody (Roche, Basel, Switzerland).
Images were captured with a charge-coupled device camera system (Photomet-
rics sensys; Roper Scientific, Inc., Trenton, N.J.). The analysis of fluorescein
isothiocyanate fluorescence signals on propidium iodide-colored chromosomes
was performed with FISH software MacProbe (Perceptive Scientific Instruments,
Inc.).
Hybrid cell mapping. PCR typing of TLR9 was performed in a cattle-mouse
somatic-hybrid cell (SHC) panel (55), and in a cattle-hamster 5,000-rad whole-
genome radiation hybrid panel WGRH5000 (54), essentially as described previ-
ously (18). The WGRH typing experiment was performed twice, and data were
scored independently. PCR products were scored as present (1), absent (0), or
ambiguous (2). Two-point linkage analysis was done by using the software
RHMAPPER (47) to assign the TLR9 locus to a chromosome and a nearest
marker of the bovine WGRH5000 gene map (3).
Real-time RT-PCR quantitation of mRNA copy numbers. We used real-time
PCR with the LightCycler Instrument (Roche) to determine the relative copy
numbers of the different mRNA moieties, essentially as described previously
(31). All RNA samples were extracted with the TRIZOL reagent (Invitrogen)
and purified further with the RNase-free DNase set (Qiagen), as prescribed in
the kit. For cDNA synthesis, 1 g of total RNA was primed in reverse with a
mixture of four different reverse oligonucleotide primers (25 pM of each per
assay), with one specific for each of the different mRNAs. After first-strand
synthesis (H Superscript; Invitrogen) and cDNA purification, aliquots equiva-
lent to 12.5 ng of total RNA were distributed to four different vials. Next,
gene-specific primer pairs were added and segments of the cDNA were amplified
by using the Fast-Start Sybr Green I kit (Roche). Gains in fluorescence intensity
were assayed at temperatures previously optimized for each gene (between 78
and 86°C). Relative copy numbers of the individual mRNA moieties were cal-
culated from a dilution series (106 to 10 copies) of the respective cDNA sub-
clones. All samples were measured twice from two independent cDNA prepa-
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rations. We resolved all Light-Cycler amplificates after each run on agarose gels
to monitor their quality.
The following primers have been used for cDNA priming of the BNBD5
mRNA primer cDE8r (5-CGTGTGTTTGCCTTCTTTTACCA), and 149 bp
was amplified by combining cDe8f (5-CTGGATCACCTGCTCCTCGT) with
gD8ex2r (5-GGTGCCAATCTGTCTCATGTTG). The latter primer was opti-
mized against all available bovine -defensin cDNA sequences so that the 3-
terminal nucleotides do not attach to any other of these sequences. Both BNBD5
primers are located on different exons, separated by 1,480 bp of intron sequence.
TLR2 mRNA was primed in reverse with b_TLR2rn (5-GATCTTCCGCAGC
TTACAGAAG), and the primer combination b_TLR2f (5-CATTCCCTGGC
AAGTGGATTATC) and b_TLR2r2 (5-GGAATGGCCTTCTTGTCAATGG)
amplified 195 bp. The TLR4 cDNA was primed with b_TLR4rn (5-TGCACA
CATCATTTGCTCAGCT), and 237 bp was amplified with the primers b_TLR4f
(5-CACTCCCTCTCTAGCCTTCAG) and b_TLR4r (5-CCTTGACCCACTG
CAGGAAAC). The cDNA of the TLR9 mRNA was primed with TLR9r2
(5-GCAAGTGGTGGATGCGGTTG), and 84 bp was amplified with primer
pair TLR9fn-TLR9r3 (5-ACTGGCTGTTCCTGAAGTCTGT and 5-GAGAT
TAAGGAGAGGCTGGTGA, respectively). The authenticity of all products
amplified by applying this protocol was verified by subcloning and sequencing of
the PCR products.
In situ hybridization. Ribonucleotide probes for the detection of the BNBD5-
encoding messages were transcribed in vitro from a full-length cDNA cloned in
opposite orientations into the vector pGEM-Teasy (Promega, Mannheim, Ger-
many). We used the T7 polymerase to transcribe both sense and antisense probes
and label them nonradioactively with the digoxigenin RNA labeling kit (Roche).
Seven-micrometer sections were cut from paraformaldehyde (4%)-fixed and
wax-embedded specimen. We followed the general procedures for the in situ
hybridizations as described previously (33), with the following modifications.
Slides were air dried after dewaxing, permeabilized with proteinase K (20 g/ml),
and acetylated. Next, the sections were denatured on a heat block (80°C, 2 min)
to enhance the sensitivity of the hybridizations, cold shocked on ice, and subse-
quently maintained on a heating plate at 65°C. We applied (per section) 30 l of
hybridization mix containing 7 ng of the labeled probe, hybridized the mixture
overnight at 58°C, washed it twice at 60°C (50% formamide, 2	 SSC [1	 SSC is
0.15 M NaCl plus 0.015 M sodium citrate]) and subsequently in 0.2	 SSC at
room temperature. Unbound probe molecules were removed by RNase digestion
(37°C for 30 min with RNase A [10 g] and T1 [100 U/ml] in 2	 SSC). Signals
were detected by applying anti-digoxigenin Fab fragments conjugated with the
alkaline phosphatase and chromogenic substrates, as provided in the nucleic acid
detection kit (Roche). Pilot experiments, applying all steps but excluding the
probes, had revealed the necessity of including 5 mM levamisole in the substrate
buffer for the development of the hybridization signals in mammary gland sec-
tions to prevent nonspecific background staining.
Statistical analyses. All statistical analyses were conducted with the SigmaStat
program package (Jandel Scientific, San Rafael, Calif.). Means were compared
with the Mann-Whitney rank sum square test, and correlations were assessed
with the Spearman rank order correlation.
Nucleotide sequence accession number. Nucleotide sequences were deposited
in National Center for Biotechnology Information database (http://www.ncbi.n-
lm.nih.gov/) and assigned the following accession numbers: TLR9 cDNA,
NM_183081; TLR9 gene, AJ509824; BNBD5, A278799.
RESULTS
Characterization of the bovine TLR9 cDNA sequence and
gene structure. We have isolated and sequenced the gene
encoding the entire bovine TLR9 and its cDNA equivalent.
FIG. 1. Nucleotide and amino acid sequences of the N terminus of the bovine TLR9-encoding gene. (A) 5-Terminal sequence of the
TLR9-encoding gene. The sequence is from BAC clone 820 and is also shown as retrieved from 5-RACE clones (bold face letters). The most
5-located nucleotides, as retrieved from the longest 5-RACE clones, from various tissues are specified (, mammary gland; §, brain; #,
macrophages). Two SP-1 boxes are located in the presumed promoter sequence. An intron (splice donor and acceptor dinucleotides are
underlined) separates the translational start codon from the rest of the coding sequence (codons are indicated). The sequence around the 5 splice
donor dinucleotide is precisely conserved between cattle, humans, and mice (boxed). (B) Comparison of the N-terminal amino acid sequence of
TLR9 factors. The bovine signal peptide is shorter by 1 aa residue than those from humans and mice (:, identical residues; ., equivalent amino acid
residues).
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The cDNA sequence, as retrieved, comprises 123 bp of the 5
untranslated region (UTR), an open reading frame of 3,090
bp, and 43 bp from the 3 UTR. We conducted 5 RACE
experiments with RNA extracted from different tissues and
cells to detect possible tissue-specific splice variants. However,
the 5 ends of the 19 different 5 RACE clones sequenced from
the different sources (mammary gland, brain, and activated
macrophage suspensions) all clustered narrowly, and we define
as 1 the 5 nucleotide of our longest 5 RACE clone (Fig.
1A). The 5-adjacent sequence features two canonical SP-1
binding sites but no TATA box. The exact promoter definition
awaits further analyses.
The architecture of the TLR9-encoding gene is conserved
between cattle, humans, and mice. Sequence analysis of our
BAC clone 820 reveals that exon 1 encodes the 5 UTR and is
3-terminated by the translational start codon ATG (Fig. 1A),
similar to that in humans (16) and in mice (EMBL database
file NW_000356). The intervening intron spans 1,010 bp in
cattle but 1,215 bp in humans due to the insertion of an Alu
repeat element (EMBL file NT_005986). Exon 2 encodes the
entire body of the protein and the 3 UTR. The 3 UTR is
conceivably longer than the short segment retrieved, but the
adaptor-primers from the Marathon kit used for these exper-
iments bound always to the GC-rich sequence element of the
proximal 3 UTR. No efforts were made to sequence further
downstream on our BAC isolate 820.
The nucleotide sequence encoding the bovine TLR9 is 83.5
and 76.9% similar to the homologous genes from humans and
FIG. 2. Mapping of TLR9 on cattle chromosome 22. (A) FISH of probe BAC 820 on a G-banded cattle metaphase spread prior to (A1, arrows
specify chromosome 22) and after (A2) hybridization. Strong fluorescein signals can be seen in the telomeric region of chromosome BTA22.
(B) TLR9 was assigned to position q24 of BTA22, according to the International System for Chromosome Nomenclature of Domestic Bovids 2000
for G-banded cattle chromosomes. (C) Assignment of TLR9 on the WGRH5000 map.
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mice, respectively. Conceptual translation of the bovine se-
quence shows that the bovine protein comprises 1,029 amino
acid (aa) residues, and hence, is shorter by 3 aa residues than
the homologous receptors from both other species. The entire
protein sequence of the bovine receptor is 79.5 and 73.5%
similar to those of humans and mice, respectively. However,
the sequence of the N-terminal 7 aa of the TLR9 protein is
divergent between all three species (Fig. 1B). Indeed, the sig-
nal peptide of the bovine receptor is shorter by 1 aa residue
than that of the other two species.
The bovine TLR9-encoding gene is localized on BTA22.
FISH with our BAC isolate 820 revealed that the TLR9-en-
coding gene is located on chromosome 22 (Fig. 2A). Using the
G bands, we mapped TLR9 on band q24 (Fig. 2B). The as-
signment was confirmed by PCR typing on the SHC panel.
TLR9 was assigned a position on BTA22 close to the reference
marker HRH1, which had previously been mapped to the
distal part of the chromosome (3). We found 97% concordance
for the assigned gene in this assay, thus well above the widely
accepted threshold value of 0.87 (9). PCR typing in the
WGRH5000 panel was performed based on these SHC map-
ping results. Fourteen positive PCR signals in the 90 RH cell
lines selected for PCR typing resulted in a retention frequency
of 0.16 in an RHMAPPER two-point linkage analysis com-
bined with the data of the cattle WGRH5000 gene map. This
confirms the assignment of TLR9 to BTA22. TLR9 was placed
between MAP4 and EST1649, with the strongest linkage to
MAP4 (decimal log likelihood ratio score, 17.5) and a calcu-
lated distance of 3 cR5000 to MAP4 (Fig. 2C).
Infection of udder tissue enhances significantly the expres-
sion of BNBD5, TLR2, and TLR4 but not that of TLR9. We
wanted to examine the effect of mammary gland infection upon
the abundance of the messages from these genes. Hence, sam-
ples were collected from pathologically and anatomically dis-
eased (presumed infected) and healthy (presumed uninfected)
glands. The bacteriologic typing of the latter samples revealed,
however, that 9 of the 19 presumed uninfected glands gave rise
to a few bacterial colonies in these evaluations, whereas all
TABLE 1. Samples and mRNA copy numbers of the various genesa
Animal no. Comment Pathogen(s) Degree
No. of copies of:
BNBD5 TLR2 TLR4 TLR9
1 Control 0 30 65 41 43
2 Control 0 72 999 2,167 366
3 Control 0 95 253 449 469
4 Control 0 288 1,666 3,176 2,653
5 Control 0 20 2,373 1,435 381
6 Control 0 124 1,292 3,959 1,204
7 Control 0 12 14 10 19
7 S. aureus, A. pyogenes 3 476 1,401 3,113 1,777
8 Control 0 1,582 2,269 5,795 342
8 S. dysgalactiae 1 1,916 6,797 8,348 ND
9 Control 0 25 4,398 1,343 216
9 E. coli, A. pyogenes 3 182 7,643 7,360 616
10 Control 0 19 534 396 116
10 S. canis 3 438 18,184 4,979 1,132
11 Control E. coli 1 37 593 2,296 394
12 Control S. aureus 1 504 7,354 10,568 1,319
12 Enter 2 958 2,458 8,148 2,548
13 Control S. aureus 1 129 1,107 2,040 2,556
13 S. aureus 3 5,399 6,553 5,676 456
14 Control Unspec 1 3,151 4,754 4,905 4,254
14 E. coli 3 5,425 4,712 4,580 515
15 Control Unspec 1 311 6,348 7,194 691
15 E. coli, A. pyogenes 3 74 3,813 5,871 492
16 RF, control S. uberis 1 462 547 758 17
16 RB, control S. uberis 1 1,510 2,783 8,919 270
16 LF, infected S. aureus 3 4,160 7,149 16,039 420
17 RF, control Cory 1 716 2,591 14,324 892
17 RB, infected Cory 2 3,001 2,670 6,121 250
18 LF, chronic SC S. aureus 2 121 10,919 5,889 175
18 LB, C, infected S. aureus 3 6,617 75,311 63,230 1,608
18 LB, A, infected S. aureus 3 2,022 21,722 17,299 362
19 S. dysgalactiae 2 71 152 294 239
20 S. aureus 2 1,860 4,726 10,401 400
21 S. uberis 3 29,383 13,859 7,877 209
22 A. pyogenes 3 2,255 2,493 7,352 339
23 A. pyogenes 3 2,262 3,094 7,325 247
24 S. uberis 3 7,500 3,795 5,141 911
25 S. dysgalactiae 3 1,861 3,985 5,787 647
a Abbreviations: LF, RF, and RB, left front, right front, and right back quarters of the udder, respectively; C and A, cisternal and alveolar area of the same udder
quarter; unspec, unspecified bacteria; chronic SC, chronic subclinical infection; Cory, corynebacterium; Enter, enterococcal species; ND, not determined, due to
consistently emerging false PCR products in this sample with these primers. Control, presumptive uninfected sample. Degree indicates the number of CFU derived
from the samples (0, none; 1, 
11; 2, 11 to 30; 3, 30).
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diseased quarters showed bacteriological contamination. Spec-
ifications of the individual samples and levels of expression of
the respective genes are presented in Table 1.
The average relative mRNA copy numbers of all four genes
were lower in the truly uninfected glands than those measured
in those samples containing bacteria (Fig. 3A). The average
concentration of the BNBD5 messages was 13 times higher in
the infected glands than in the uninfected samples. The abun-
dance of TLR2 and TLR4 messages was also increased in the
infected samples, about four- to fivefold. These differences are
significant for BNBD5 and TLR2 (P, 
0.02) and are highly
significant for TLR4 (P, 
0.001). The concentration of the
TLR9 messages, on the other hand, was only slightly increased
by mastitis, and the observed 1.4-fold increase in the abun-
dance of the TLR9 messages in the infected samples is not
statistically significant.
Severity of infection correlates with increased abundance of
messages for BNBD5, TLR2, and TLR4 but not for TLR9.
Slight infections already result in a substantial increase of the
mRNA concentrations of the former three genes (Fig. 3B).
Subgrouping the values of all samples with attributable bacte-
rial counts into slightly infected materials (Table 1, degree 1)
and pathologically and anatomically diseased (e.g., moderately
or severely infected) (Table 1, degrees 2 and 3) reveals that the
samples harboring only a few bacteria already had clearly
higher copy numbers of these three genes than those found in
the uninfected samples. The increased mRNA concentrations
of the TLR2- and TLR4-encoding genes, as measured in the
slightly infected samples, is statistically significant (P, 
0.05),
and that for BNBD5 is close to significance (P, 0.07). However,
the average mRNA concentration of all three genes is further
increased in the more severely infected glands. The average
abundance of TLR9 messages would appear doubled in the
slightly infected samples, but this increase is statistically insig-
nificant.
Induction of these genes is not systemic but is confined to
the infected quarter of the udder. Nonsystemic induction of
increased mRNA abundance in the udder becomes evident
when comparing mRNA abundances in proven uninfected
control quarters to those from the infected quarters of the
same animal (Fig. 3C; Table 1, animals 7 to 10). Infection
increases the mRNA copy numbers of all four genes, including
TLR9, over the level detected in the proven uninfected quar-
ters of the same gland. The extent of increase in the mRNA
abundances, as associated with infection, becomes even clearer
in pairwise comparisons, expressing the mRNA concentration
of the infected quarter as a multiple of the level measured in
the uninfected control quarter of the same animal. All four
mRNAs, including TLR9, are 17- to 80-fold more abundant
in the infected quarters than in the proven uninfected controls.
However, the magnitude of this factor may be somewhat ex-
aggerated, since its calculation depends heavily on the absolute
very low copy numbers measured in the uninfected glands,
which are eventually close to the background.
Coordinated increase of TLR2, TLR4, and BNBD5 mRNA
abundance. The reciprocal plot of the individual TLR2 versus
TLR4 copy numbers measured from the same samples sug-
gests a linear correlation between both values (Fig. 4A). A
clear positive and significant correlation exists between all val-
ues of these two pathogen recognition receptors (r, 0.75; P,
FIG. 3. Relationship between health status and mRNA copy num-
bers. (A) Mean relative copy numbers from the indicated genes, as
measured from proven uninfected (open columns; n  10) or infected
(filled columns; n  28) quarters of mammary glands. Error bars
indicate standard errors of the means. (B) Same as shown in panel A;
however, separating the group of infected quarters into slight subclin-
ical infections (hatched columns; n  9) and moderate or severe
infections (black columns; n  19). (C) Differences in mRNA abun-
dances between healthy control and infected quarters of the same
animal (control) (open columns; n  4). The average magnitude of
increased concentration from pairwise comparisons of control and
infected quarters of the same animal is given below the graph (pairs
[fold increase {inc.}]).
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0.001) and between those from any subgroups of data, as
from the moderately and severely infected samples alone
(r, 0.47; P, 
0.05), slightly infected samples (r, 0.63; P, 0.058)
or proven uninfected samples (r, 0.67; P, 
0.05).
The concentrations of the BNBD5 messages correlate with
those of TLR2 (r, 0.60;, P, 
0.001) and TLR4 (r, 0.66; P,

0.001) (Fig. 4B). The statistical significance stems in both of
these comparisons from the 19 uninfected or slightly infected
samples (r, 0.64; P, 
0.003; r, 0.79; P, 
0.001) for TLR2 and
TLR4, respectively. These correlations are statistically insig-
nificant in the moderately and severely infected samples.
The concentrations of TLR9-encoding messages, on the
other hand, are not correlated with any one of those from the
other genes examined.
S. aureus increases strongly the abundances of all mRNAs
examined except TLR9. The bacteriologic evaluation of the
infected quarters had revealed a variety of pathogenic bacteria.
S. aureus was the sole pathogen in eight samples. These re-
vealed much higher concentrations (8- to 12-fold) of the
mRNAs from BNBD5, TLR2, and TLR4 than measured in the
healthy quarters (Fig. 5). The level of TLR9 expression in
these samples was almost similar (1.6-fold) to those in the
controls. The rest of the infected samples were compiled into
two other groups. One of these surmises all samples harboring
all other bacteria (Streptococcus dysgalactiae, Streptococcus
uberis, Streptococcus canis, Actinomyces pyogenes, and Coryne-
bacterium) except Escherichia coli. Samples containing E. coli
form the last group. BNBD5 abundance is greatly increased in
FIG. 4. Correlated levels of TLR2, TLR4, and BNBD5 mRNA abundance. (A) Reciprocal plot of individual TLR2 and TLR4 copy numbers
from healthy (carets), slight (squares), or moderately and severely (triangles) infected quarters. Filled symbols represent subgroups with P values
of 
0.05 as the level of significance for the correlation between both parameters. (B) Relationship between TLR4 and BNBD5 mRNA
concentrations (symbols are as defined for panel A). A similar plot is obtained if the BNBD5 data are plotted against those for TLR2 (data not
shown).
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both of the latter groups. All other pathogens stimulated TLR2
and TLR4 levels in the infected glands to a lesser extent than
S. aureus. Levels of TLR9-encoding messages, however, are
not significantly modulated by any of the pathogens. The val-
ues from three samples have not been incorporated into this
comparison: the one containing enterococci and the two sam-
ples with unspecified bacteria (animals 12, 14, and 15) (Table 1).
BNBD5 is expressed in MEC. In situ hybridizations towards
serial sections of infected mammary glands were used to iden-
tify the relevant cell type expressing the bactericidal effector
gene BNBD5 within the gland. The antisense probe hybridized
towards mammary epithelial cells (MEC) of alveoli and cells
lining the milk ducts Fig. 6, whereas the sense control did not
bind specifically to these cells. The low magnification overview
shows that MEC are the predominant sites for the expression
of this gene in the infected udder. Sections from proven unin-
fected glands did not reveal any specific hybridization signal
(data not shown). These data together suggest that the patho-
genic signal is transduced to MEC within the udder to stimu-
late the expression of this effector gene of the innate immune
defense.
DISCUSSION
A TH1-driven secretion of cytokines and chemokines is nec-
essary to mount a successful defense against invading patho-
FIG. 5. Influence of pathogen species on mRNA abundance. (A) Relative copy numbers, as measured in samples infected with S. aureus (filled
bars; n  8), a spectrum of streptococcal and coryneform bacteria (hatched bars; n  13), and those containing E. coli (white bars; n  4, two of
these had E. coli as the sole pathogen, and the others contained A. pyogenes as a second pathogen). (B) Magnitude of increased copy numbers in
severely infected samples, expressed as multiples from the levels found in uninfected quarters (grouping of values is as in panel A) , P 
 0.05;
, P 
 0.001.
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gens of the udder (15). Bias towards a TH2-driven response
results in malfunction of the immune response, as frequently
encountered during early lactation and conceivably caused by
the recent pregnancy (39). Activation of TLRs influences the
polarization of the proinflammatory immune reaction towards
either a TH1 or TH2 response (12), and the outcome of this
polarization depends heavily upon the activity of subsets from
dendritic cells (34). These subsets of dendritic cells, in turn, are
characterized by different patterns of TLR expression (27).
This background prompted us to examine the possible involve-
ment of differential abundance of TLRs to counteract infection
of the udder in the cow. Levels of TLR9 expression should be
included in the survey due to its pivotal importance in mount-
ing a TH1 response (20).
Characterization and mapping of the bovine TLR9-encod-
ing gene. We had to sequence the bovine gene encoding TLR9
to allow for the measurement of the respective mRNA abun-
dance in real-time PCR assays. Moreover, characterization of
the TLR9 gene from the bovine species is a necessary prereq-
uisite for its eventual use in augmenting the strength of the
immune response in cattle, since relevant PAMPs for TLR9
are species specific (4). Our comparison of the protein se-
quences of TLR9 factors from various species reveals consid-
erable heterogeneity of the extreme N terminus. N-terminal
heterogeneity of the TLR9 factors might be relevant for the
species specificity of TLR9 signaling, since it was shown that
the N-terminal 58 aa residues are indispensable for TLR9
function (50). Assignment of TLR9 to the bovine chromosome
22 and its fine mapping provides the basis for a detailed eval-
uation of an eventual trait-related genetic variance as associ-
ated with this gene. Regarding mastitis, no quantitative trait
loci for clinical mastitis have been found on BTA 22 in ge-
nome-wide scans (28), though such studies are rare. Earlier
studies, however, had shown a quantitative trait locus on
BTA22 for the somatic cell scores trait on this chromosome
(2). This trait is also related to udder health (46). Our mapping
information allows for an efficient examination of the contri-
bution of TLR9 to either of these traits.
Influence of mastitis on the expression of the four genes.
Our key observation is that mastitis increases the abundances
of messages encoding the pathogen-specific receptors TLR2
and TLR4 in the udder together with the bactericidal peptide
BNBD5. While the demonstration of enhanced synthesis of the
encoded proteins awaits the establishment of suitable antibod-
ies against them, our data suggest conclusively that the innate
branch of the immune system contributes significantly to the
immune surveillance of the mammary gland and very probably,
to the counteraction of mastitis.
Most of the samples (except those from animals 16, 17, and
18) were collected from a commercial slaughterhouse, irre-
spective of breed and lactation status. Hence, we have no
records regarding the clinical history of the animals or other
parameters reflecting the degree of inflammation or progres-
siveness of mastitis in the respective udder quarters, e.g., cell
counts of somatic cells in the milk. However, all udder quarters
scored on the basis of bacterial counts as moderately or se-
verely infected had shown pathological alterations of the tis-
sue, indicating ongoing mastitis at the time of sampling. Some-
what unclear, however, is the degree of inflammation in those
nine presumptively uninfected control udders, whose samples
gave rise to a few CFU. While we cannot exclude bacterial
contamination during sampling, it is obvious that some of these
revealed considerably higher expression of BNBD5, TLR2,
and TLR4 and hence may have been inflamed at the time of
sampling (Table 1, degree 1; Fig. 3B). Clearly, a decisive anal-
ysis of the interdependence between the onset of inflammation
and increased abundance of the factors of the innate immune
system inside the udder requires a different experimental ap-
proach.
We target the MEC as a highly relevant effector cell of the
immune surveillance in the mammary gland of the cow, since
the MEC is the predominant source of -defensin 5 expression
in the infected gland. This settles for the cow ambiguities which
arose in humans concerning the role of inducible defensin
expression in mammary glands. While the constitutively active
human hBD-1-encoding gene was found to be expressed in the
human MEC (51), the authors failed to find expression of the
inducible hBD-2 gene in their mammary samples. Our data
show that the bovine BNBD5 gene is expressed in MEC and
that expression of this gene is induced by pathogenic bacteria.
Hence, MEC are highly relevant effector cells of the innate
immune defense for the cow.
The correlated increase in the abundance of TLR2 and
TLR4 messages suggests that expressions of these two recep-
tors are regulated in concert. Both receptors are known to
form eventually heterodimers (37), supporting our observa-
tion. It has recently been shown that their different agonists
(peptidoglycan and LPS, respectively) elicit different effector
functions in macrophages (8, 36), suggesting a possible differ-
ential pathogen-specific effect upon their regulation. Our data,
however, indicate clearly that they are regulated alike during
the complex events of mounting the immune response in the
udder.
The cell types expressing the TLRs in the mammary gland
await further analyses. The sensitivity of our in situ hybridiza-
tions was not sufficient to detect these messages in our mam-
mary gland sections with this method. Conceivably, a substan-
tial proportion of the increased abundance of these mRNAs
may be attributed to PMNs which are copiously recruited into
the infected udder quarter as a consequence of infection (23,
38). Assuming coordinated synthesis of these two TLRs in
PMNs could explain the unexpected result that pure S. aureus
infections increase the TLR4 mRNA abundance in the in-
fected udder. Otherwise, it might seem paradoxical that
FIG. 6. BNBD5 is expressed in MEC and cells lining the milk ducts. Mammary gland sections of an udder were hybridized with either the
antisense probe (A to C) or the sense control (D) of the BNBD5-encoding gene. The signal was developed for 20 h. The reddish label is found
in MEC lining the milk ducts and in collapsed alveoli, and it is in its highest concentrations at basolateral locations inside the cells. The samples
were taken from a slaughtered cow which had not been milked for 2 weeks, due to the infection. Parallel samples revealed high levels of BNBD5
in real-time RT-PCR quantification. Magnification, 	40 (A) and 	200 (B to D).
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PAMPs from a gram-positive pathogen increase the abun-
dance of TLR4, the proven receptor for lipid A, a relevant
PAMP from gram-negative bacteria (24). On the other hand, it
would not be surprising to find TLR2 and TLR4 expressed in
MEC as well. TLR2 was shown to drive hBD2 expression in
model cells (6), and inflammation-induced expression of TLR2
and TLR4 has been demonstrated in renal epithelial cells (53).
Given our demonstration that MEC express BNBD5, these
cells might well harbor the entire cascade of factors necessary
to transduce the signal from the pathogen to the bactericidal
effector gene.
TLR9 abundance in the mammary gland is regulated differ-
ently from the other two TLRs. We did not observe any indi-
cation for coordinated expression of this pathogen-specific re-
ceptor neither with other TLRs nor the BNBD5-encoding
gene. The insignificant small extent of mastitis-related increase
in the abundance of this mRNA moiety in the udder together
with the lacking correlation of the TLR9 mRNA abundance
with any of the other parameters examined suggests that this
receptor is expressed in a different compartment of the udder.
Mastitis does not enhance the expression of this factor nor
does it recruit such cells into the gland expressing it in high
levels. TLR9 is known to be expressed in professional antigen-
presenting cells, such as dendritic cells (27) and immune cell-
rich tissues (10).
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